Price
$97.50+3.28%Social Signal Score
Analyst Ratings
42 analysts52-week range
- Last close
- $97.50
- Off 52w high
- -27.6%
- 200-day average
- $104.01
- vs 200-day
- -6.3%
Revenue
$12.59B+137.51%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Robert Ford
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 115,000
- Beta
- 0.59
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 3.14
Financials
Revenue
$12.59B+137.5%Net Income
$928.00MEBITDA
$1.78B+681.6%Free Cash Flow
$2.89B+219.0%EPS (diluted)
$0.53Shares Outstanding (diluted)
1.74B+18.1%Operating Expenses
$4.86BCash & Debt
$5.60BReturn of Capital
$2.15BRevenue by Segment (annual)
$44.31BDividend per Share
$0.63Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $44.33B | $6.52B | $3.74 |
| 2024 | $41.95B | $13.40B | $7.67 |
| 2023 | $40.11B | $5.72B | $3.30 |
| 2022 | $43.65B | $6.93B | $3.94 |
| 2021 | $43.08B | $7.07B | $3.97 |
| 2020 | $34.61B | $4.50B | $2.52 |
| 2019 | $31.90B | $3.69B | $2.07 |
| 2018 | $30.58B | $2.37B | $1.35 |
| 2017 | $27.39B | $477.00M | $0.27 |
| 2016 | $20.85B | $1.40B | $0.95 |
| 2015 | $20.41B | $4.42B | $3.00 |
| 2014 | $20.25B | $2.28B | $1.51 |
| 2013 | $21.85B | $2.58B | $1.66 |
| 2012 | $39.87B | $5.96B | $3.78 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ABT's reported EPS growth of -0.1% a year over 13 years.
- EPS in 5 years
- $3.72
- Implied price
- $126.34
- Return from $97.50
- 5.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $62.81 — -35.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 24 | 29 | 34 | 39 | 44 |
|---|---|---|---|---|---|
| -10.1% | -11.6% | -8.2% | -5.2% | -2.6% | -0.2% |
| -5.1% | -6.7% | -3.1% | 0.0% | 2.8% | 5.3% |
| -0.1% | -1.8% | 2.0% | 5.3% | 8.2% | 10.9% |
| 4.9% | 3.1% | 7.1% | 10.6% | 13.7% | 16.4% |
| 9.9% | 8.1% | 12.2% | 15.9% | 19.1% | 22.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
10-84.44%Social Signal Score
Mentions (89)
- Newsprnewswire.com·1d ago·Negative
…ents take a more active role in their care and stay connected to their care teams between doctor visits ABBOTT PARK, Ill., Oct. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App.
View source ↗ - Newszacks.com·4d ago·Positive
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.
View source ↗ - Newsfool.com·4d ago·Positive
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? Abbott Laboratories offers a highly diversified revenue stream across medical devices, diagnostics, and nutrition. Intuitive Surgical maintains a dominant lead in robotic-assisted surgery with high recurring revenue from instruments and services.
View source ↗ - News (RSS)zerohedge·4d ago·Negative
The Data Center Boom Faces Mounting Obstacles The Data Center Boom Faces Mounting Obstacles By Brian Martucci of UtilityDive, The U.S. data center boom has entered a new, contradictory phase. On the one hand, both data center construction activity and credible forecasts for near-term capacity additions to the electric grid to serve data centers remain robust. The Electric Power Research Institute, for example, said in February that data centers will represent up to 17% of U.S. electricity demand
View source ↗ - Newszacks.com·5d ago·Neutral
Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know The latest trading day saw Abbott (ABT) settling at $98.83, representing a -2.1% change from its previous close.
View source ↗ - News (RSS)zerohedge·6d ago·Neutral
Texas Governor Declares Disaster Over Soaring Diesel Prices Texas Governor Declares Disaster Over Soaring Diesel Prices Texas ranchers and truckers could start seeing some relief at the fuel pump starting this week after Gov. Greg Abbott proclaimed a statewide disaster on Sept. 28 to ease diesel shortages. "Texas agriculture and freight run on diesel," Abbott said in a statement. "Record prices put both industries at risk and raise costs for every Texas family." Record-high diesel prices in the
View source ↗ - News (RSS)forbes·6d ago·Neutral
Abbott Moves Again To Slam The Brakes On Texas Data Center Growth Texas Governor Greg Abbott moved again to slow the expansion of data centers in his state amid a close re-election campaign.
View source ↗ - News247wallst.com·7d ago·Negative
3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth Pacemakers and glucose monitors keep selling whether the economy booms or collapses, and three medical device giants have spent decades turning that predictable demand into paychecks that grow every single year.
View source ↗ - News (RSS)zerohedge·10d ago·Neutral
Efforts To Curb Data Center Speculation Gain Ground Across The US Efforts To Curb Data Center Speculation Gain Ground Across The US By Brian Martucci of UtilityDive, “A fraction of proposed data centers will get built. Utilities are wising up.” That was the headline on a May 2025 Utility Dive article that explored the conundrum speculative data center requests pose for U.S. electric utilities. More than a year later, it’s unclear how much has changed. Sections of the Stargate Oracle AI data cent
View source ↗ - Newsfoxbusiness.com·11d ago·Neutral
CEO warns high diesel costs could trigger a 'vicious cycle' of surging food prices Pivot Bio CEO Chris Abbott warns food prices could remain elevated for at least a year as rising diesel costs drive up expenses for farmers during harvest season.
View source ↗ - Newszacks.com·11d ago·Neutral
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note Abbott (ABT) concluded the recent trading session at $101.07, signifying a -2.34% move from its prior day's close.
View source ↗ - News (Marketaux)finance.yahoo.com·12d ago·Positive
What Makes Abbott Laboratories (ABT) an Attractive Opportunity? In its second-quarter 2026 investor lett[+384 characters]
View source ↗ - Newszacks.com·12d ago·Neutral
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - News (RSS)zerohedge·13d ago·Negative
Texas Governor Orders Halt To New Data Centers Weeks After Issuing Moratorium Texas Governor Orders Halt To New Data Centers Weeks After Issuing Moratorium One month after Texas Governor Greg Abbott ordered a pause on Texas data center approvals pending an audit, overnight the governor doubled down and ordered the state’s environmental watchdog to withhold permits for new data centers until an audit of risks to the power grid is complete. No authorizations can be given until the Electric Reliabi
View source ↗ - News (RSS)cnbc·14d ago·Positive
Texas Gov. Abbott orders data center permit halt weeks after issuing moratorium Data centers have been a flash point in the 2026 midterm elections, including Abbott's bid for reelection against Democratic state Rep. Gina Hinojosa.
View source ↗ - News (RSS)zerohedge·14d ago·Negative
Houston-Area Birth Tourism Center Shut Down In Legal Action Houston-Area Birth Tourism Center Shut Down In Legal Action Authored by Kimberly Hayek via The Epoch Times, A birth tourism operation in the Houston area has agreed to close in a settlement, Texas Attorney General Ken Paxton announced on Friday. An advertisement for a Houston-area “birth tourism” operation known as De’Ai Postpartum Care Center. The Texas attorney general filed a lawsuit against the center, claiming it has operated an un
View source ↗ - Newsfool.com·14d ago·Neutral
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth Abbott Laboratories (ABT +0.54%) primarily generates its revenue by researching, developing, manufacturing, and distributing a diverse portfolio of medical devices, diagnostic test systems, nutritional formulas, and generic pharmaceutical products across international healthcare networks.
View source ↗ - News (RSS)zerohedge·17d ago·Neutral
Minnesota Authorities Arrest ICE Agent On State Assault Warrant In January Shooting Minnesota Authorities Arrest ICE Agent On State Assault Warrant In January Shooting Authored by Kimberly Hayek via The Epoch Times, A U.S. Immigration and Customs Enforcement (ICE) agent wanted on state charges of assault and false reporting was arrested Wednesday in downtown Minneapolis eight months after the shooting of a Venezuelan man during an immigration enforcement operation. Protesters gather at the Bisho
View source ↗ - Newsfool.com·18d ago·Positive
Why Wall Street Is Becoming Even More Bullish About This Dividend King Wall Street analysts have raised price targets on Abbott, citing accelerating growth in its Medical Devices segment. Abbott's diabetes, electrophysiology, and new Exact Sciences cancer-screening businesses are driving stronger sales and earnings.
View source ↗ - News (RSS)seekingalpha·18d ago·Neutral
Abbott Laboratories declares $0.63 dividend
View source ↗ - Newsprnewswire.com·18d ago·Negative
Abbott declares 411th consecutive quarterly dividend ABBOTT PARK, Ill., Sept. 17, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.
View source ↗ - Newszacks.com·19d ago·Neutral
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
View source ↗ - News (Marketaux)insurancejournal.com·20d ago·Negative
Abbott to Pay $385 Million to End Claims Over Infant Formula Abbott Laboratories ag[+211 characters]
View source ↗ - News (Marketaux)gurufocus.com·20d ago·Positive
ABT Looks 22.9% Undervalued on GF Value™ On September 15, 2026, Abbott <[+338 characters]
View source ↗ - News (RSS)straitstimes·21d ago·Neutral
Abbott to pay $489m to settle infant formula allegations Reports of unsanitary conditions surfaced, including roof leaks, deteriorating equipment and inadequate cleaning procedures.
View source ↗ - News (RSS)guardian·21d ago·Neutral
Texas governor threatens to penalize datacenters not obeying water laws Republican Greg Abbott says datacenters must help ‘protect’ drought-prone state and disclose water useGreg Abbott, the Texas governor, has directed state regulators to penalize datacenters that fail to comply with state laws requiring them to disclose their water use.“Data centers must share the duty to protect Texas water,” the Republican governor said on Monday. “The Texas Water Code requires a complete and accurate water
View source ↗ - News (Marketaux)gurufocus.com·21d ago·Positive
ABT Looks 22.9% Undervalued on GF Value™ with Strong Dividend Sustainability On September 14, 2026, Abbott <[+321 characters]
View source ↗ - Newszacks.com·21d ago·Neutral
Abbott (ABT) Rises As Market Takes a Dip: Key Facts Abbott (ABT) closed the most recent trading day at $103.09, moving +1.12% from the previous trading session.
View source ↗ - News (RSS)forbes·21d ago·Neutral
Abbott Settles Baby Formula Claims For $385 Million Abbott will pay $385 million to settle state, federal, and civil lawsuits stemming from contamination issues at its Michigan baby formula plant in early 2022.
View source ↗ - Newsreuters.com·21d ago·Neutral
Abbott to pay $384 mln over contaminated infant formula allegations, US Justice Dept says Abbott Laboratories has agreed to pay more than $384 million to settle allegations related to contaminated infant formula, the U.S. Justice Department said on Monday.
View source ↗ - Newsprnewswire.com·21d ago·Negative
…i No unopened, distributed Abbott infant formulas have ever tested positive for Cronobacter sakazakii ABBOTT PARK, Ill., Sept. 14, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) has reached an agreement to resolve the previously disclosed investigation and lawsuit brought by the United States Department of Justice, as well as lawsuits filed by certain relators and the Attorneys General of several states, relating to Abbott's manufacturing and 2022 recall of powdered infant formula at its facility in St…
View source ↗ - Newszacks.com·24d ago·Neutral
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
View source ↗ - Newszacks.com·26d ago·Neutral
Abbott Receives FDA Nod for TactiFlex Duo: Stock to Gain? FDA approval for TactiFlex Duo expands ABT's AFib ablation portfolio with dual PFA and RF energy options, supporting broader U.S. adoption.
View source ↗ - Newszacks.com·27d ago·Neutral
Here's Why Abbott (ABT) Fell More Than Broader Market Abbott (ABT) concluded the recent trading session at $105.52, signifying a -2.59% move from its prior day's close.
View source ↗ - News (RSS)zerohedge·28d ago·Neutral
Hartnett: A Democratic Sweep Will Trigger A Stock Market Rout, And Pop The AI Bubble Hartnett: A Democratic Sweep Will Trigger A Stock Market Rout, And Pop The AI Bubble The biggest story last week was not the unexpectedly hot jobs report which, unfortunately, will be revised sharply lower next month as the labor market reverts to its deteriorating, AI-enhanced, trendline: Instead, what everyone was - or should have been focusing on - was the bottom falling out of the bond market with global yie
View source ↗ - News (Marketaux)finance.yahoo.com·30d ago·Neutral
Schwab Dividend ETF holders: Compare it to Vanguard dividend ETF The top holdings tell the story: Merck, [+321 characters]
View source ↗ - PodcastAll In·31d ago·Positive
liberties. And I think they're going to come out in favor of open. Yeah, I think that's correct. And I think I was talking to Politico because they were reporting on the story. You know, Trump is going to turn out to be right about this data center issue. The greatest thing a community can do is to get these data centers now. When the data center providers are willing to pay your local taxes for your schools to give incentives to pay people off in any number of ways. And to move them wherever th
View source ↗ - PodcastAll In·31d ago·Positive
who now are on a G hot against data centers in order to win their midterm elections. And that is what's truly scary. They have now taken to our caches pose all of this. And we have horseshoe very sacks. You have Steve Bannon, Shapiro, Abbott and the lunatic, socialist, fringe left, all in agreement. We need to stop AI, stop the data centers, and burn the way modes in the street. It's a truly troubling moment because we are poised with Jensen's move in hugging face to win open source. And we've a
View source ↗ - News (RSS)zerohedge·33d ago·Neutral
Dallas Police To Shut Down Hundreds Of Flock Cameras Dallas Police To Shut Down Hundreds Of Flock Cameras Authored by Jack Phillips via The Epoch Times, The police department in Dallas has announced it will shut down hundreds of Flock cameras due to a funding pause, making it another U.S. city to remove the controversial camera system. Two Flock Safety cameras in a neighborhood in Jessup, Md., on Aug. 26, 2026. Madalina Kilroy/The Epoch Times The department said in a social media post on Sept. 1
View source ↗ - Newszacks.com·33d ago·Neutral
Abbott (ABT) Exceeds Market Returns: Some Facts to Consider The latest trading day saw Abbott (ABT) settling at $110.47, representing a +1.41% change from its previous close.
View source ↗ - News (Marketaux)investors.com·35d ago·Positive
How Abbott Laboratories Is Embracing RFK Jr.'s Make America Healthy Again Movement Abbott Laboratories (A[+161 characters]
View source ↗ - News247wallst.com·35d ago·Neutral
Two Recessions Couldn't Stop These 4 Healthcare Stocks From Raising Dividends Two brutal recessions wiped out dividends across the market, yet a handful of healthcare companies kept raising their payouts through every quarter of both downturns.
View source ↗ - Newsprnewswire.com·36d ago·Negative
Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula New Similac 360 Total Care Made With Whole Milk combines creamy whole milk for a fat blend that more closely resembles the fats in breast milk and five immune-nourishing prebiotics to help support baby's natural defenses—making it Similac's closest formula to breast milk Abbott's liquid-only launch reflects growing parent interest in in
View source ↗ - Newszacks.com·38d ago·Positive
Why Abbott (ABT) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newszacks.com·39d ago·Positive
Abbott (ABT) Stock Sinks As Market Gains: Here's Why Abbott (ABT) concluded the recent trading session at $111.59, signifying a -2.2% move from its prior day's close.
View source ↗ - News247wallst.com·39d ago·Neutral
The FDA Just Gave Abbott a Diabetes First. Is Its Beaten-Down Stock Ready to Wake Up? Abbott just scored a regulatory first in diabetes care that no rival has matched, yet the stock sits well below where it traded a year ago. The real question is what it will actually take to close that gap.
View source ↗ - Newsprnewswire.com·40d ago·Negative
…isk of a stroke Recent clinical trial data show Amulet 360 met benchmarks for safety and effectiveness ABBOTT PARK, Ill., Aug. 27, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced today it has received CE Mark for the Amulet 360™ Left Atrial Appendage (LAA) Occluder, a next-generation device designed to reduce risk of stroke in patients with atrial fibrillation (AFib) not caused by a heart valve issue (non-valvular).
View source ↗ - News (RSS)yahoo·40d ago·Neutral
Pfizer vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
View source ↗ - News (RSS)zerohedge·40d ago·Neutral
You Know Things Are Bad When This Has To Be Referred To The DOJ... You Know Things Are Bad When This Has To Be Referred To The DOJ... Authored by Steve Watson via Modernity News, Texas Governor Greg Abbott is escalating the fight against what he calls discriminatory religious facilities at two of the state's busiest airports. After DFW Airport scrapped plans for more Islamic ablution stations under pressure, Abbott has referred both Dallas-Fort Worth International Airport and Houston's George Bu
View source ↗ - News (Marketaux)gurufocus.com·41d ago·Positive
ABT Looks 12.3% Undervalued on GF Value™ Amid Strong Dividend Profile On August 25, 2026, Abbott [+243 characters]
View source ↗ - News (RSS)investing·41d ago·Neutral
Abbott receives FDA authorization for dual glucose-ketone sensor
View source ↗ - Newsreuters.com·41d ago·Negative
FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients The U.S. Food and Drug Administration said on Tuesday it authorized Abbott Laboratories' glucose monitor, making it the first device that continuously monitors both ketone levels and blood sugar.
View source ↗ - Newsprnewswire.com·41d ago·Negative
…tal health ecosystem; designed for compatibility with leading automated insulin delivery (AID) systems ABBOTT PARK, Ill., Aug. 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, the world's first dual glucose‑ketone sensing technology.
View source ↗ - Newsdefenseworld.net·42d ago·Negative
Gateway Wealth Partners LLC Sells 15,431 Shares of Abbott Laboratories $ABT Gateway Wealth Partners LLC lessened its stake in shares of Abbott Laboratories (NYSE: ABT) by 64.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,564 shares of the healthcare product maker's stock after selling 15,431 shares during the quarter. Gateway Wealth
View source ↗ - News (RSS)yahoo·42d ago·Neutral
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
View source ↗ - News (RSS)zerohedge·42d ago·Neutral
Texas Governor Floats Prosecution Of Airports Over Muslim Foot-Washing Fountains Texas Governor Floats Prosecution Of Airports Over Muslim Foot-Washing Fountains Authored by Jeremy Lott via The Epoch Times, Texas Gov. Greg Abbott, a Republican, made his second push in two weeks to halt the Muslim foot washing facilities at his state's airports on Friday. "DFW [Dallas Fort Worth International Airport] stopped plans to install additional Islamic wudu washing facilities after I threatened to withho
View source ↗ - Newszacks.com·42d ago·Negative
Here's What Is Shaping Abbott's Diagnostics Growth ABT's Diagnostics growth is being reshaped as weaker respiratory testing offsets healthy routine demand and 13% cancer diagnostics growth.
View source ↗ - News (RSS)yahoo·43d ago·Positive
Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?
View source ↗ - News (Marketaux)insidermonkey.com·43d ago·Positive
Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside? On one side is Abbott Labor[+311 characters]
View source ↗ - News (RSS)yahoo·43d ago·Neutral
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
View source ↗ - News (RSS)yahoo·43d ago·Positive
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?
View source ↗ - News (RSS)fool·43d ago·Positive
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? These two high-quality dividend payers have had very different fortunes recently.
View source ↗ - Newsprnewswire.com·43d ago·Neutral
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion /PRNewswire/ -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today announced that it has
View source ↗ - News (Marketaux)finance.yahoo.com·43d ago·Positive
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? Its largest positions include Abbott[+218 characters]
View source ↗ - Newsfool.com·43d ago·Positive
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? Abbott Laboratories has faced challenges, but it should successfully overcome them. Johnson & Johnson is performing well, and there could be more to come ahead.
View source ↗ - News (Marketaux)cnbc.com·45d ago·Positive
Here are the top 10 things we're watching in the stock market Friday Abbott Laboratories ha[+267 characters]
View source ↗ - News (RSS)investing·46d ago·Neutral
Abbott agrees to $670 million settlement of infant formula cases
View source ↗ - Newsreuters.com·46d ago·Neutral
Abbott agrees to $670 million settlement of infant formula cases Abbott said on Thursday it reached a $670 million settlement with three law firms to resolve legal claims by 2,000 people who alleged harms relating to the company's specialty formulas for preterm infants.
View source ↗ - Newsprnewswire.com·46d ago·Neutral
… and necessary, and there is no reliable scientific evidence that they cause necrotizing enterocolitis ABBOTT PARK, Ill., Aug. 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) has reached agreements with three law firms to resolve the Gill case and claims involving approximately 2,000 other individuals relating to the company's specialty formulas for preterm infants.
View source ↗ - News (RSS)yahoo·47d ago·Neutral
Abbott vs. Intuitive Surgical: Is Consistent Growth Better Than Premium Growth?
View source ↗ - News (RSS)investing·47d ago·Neutral
Richard W. Allen of Georgia’s 12th district makes significant trades in Abbott Laboratories and Advanced Micro Devices
View source ↗ - Newszacks.com·47d ago·Neutral
Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst ABT's Medical Devices growth is fueled by electrophysiology, expanding CGM adoption and a cardiovascular pipeline extending into 2029 and beyond.
View source ↗ - Newsseekingalpha.com·47d ago·Negative
…Phase (Downgrade) Abbott Laboratories remains a high-quality, diversified healthcare leader with renewed momentum across nutrition, diagnostics, and medical devices. ABT's Q2 2026 saw accelerating 4.8% YoY sales growth and broad-based profitability improvement, with adjusted gross margin up 100 bps to 58.0%. Growth catalysts include the Exact Sciences acquisition for cancer diagnostics, innovative PFA solutions in electrophysiology, and a nutrition turnaround.
View source ↗ - Newsseekingalpha.com·48d ago·Positive
…Abbott Laboratories remains a buy, with accelerating earnings growth, margin expansion, and robust segment performance following Q2's double beat and guidance raise. ABT's Exact Sciences acquisition strengthens its long-term growth runway, supporting a raised EPS outlook and 10.4% CAGR over the next six years. Despite recent price appreciation, ABT trades below its 5-year forward P/E average, offering a 2.5% yield and a potential 37% upside to a $151 price target.
View source ↗ - News (RSS)aljazeera·49d ago·Positive
CAIR slams Abbott’s ‘anti-Muslim stunt’ on Texas airport washing stations Abbott accuses airports of religious discrimination over wudu stations, calls for federal investigation.
View source ↗ - Newsprnewswire.com·49d ago·Positive
Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare The NACHC and Abbott Food for Health Initiative is a multi-year "food is medicine" effort to support the integration of nutrition as a foundational component of primary care provided by Community Health Centers (CHCs) across the country Certification program alongside training and resources are designed to help health centers offer real-world approaches that provide healthy food and su
View source ↗ - News (RSS)zerohedge·50d ago·Neutral
Dallas Airport Shelves Muslim Washing Facilities After Texas Governor Threatens Airport Funding Dallas Airport Shelves Muslim Washing Facilities After Texas Governor Threatens Airport Funding Authored by Jeremy Lott via The Epoch Times, The Dallas Fort Worth (DFW) International Airport was mulling the installation of special washing rooms to facilitate prayers by its Muslim passengers. A DFW spokesman told The Epoch Times Saturday that the airport has shelved those plans after objections by the
View source ↗ - News (RSS)yahoo·52d ago·Negative
Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health?
View source ↗ - News (RSS)hellenicshipping·52d ago·Neutral
CLARKSONS HELLAS – SnP WEEKLY Dry Cargo As mentioned, the Kamsarmax sector has seen particularly strong activity recently, with a number of around 10 years old vessels changing hands. The MEDI POSITANO (ABT 82K DWT, 2015, TSUNEISHI ZOSEN, SCRUBBER) was sold to Greek Buyers for around USD 32m. Meanwhile, the PRESINGE (ABT 82K DWT, 2015 TSUNEISHI ZHOUSHAN) has been acquired ...
View source ↗ - News (Marketaux)manilatimes.net·53d ago·Neutral
Envetec Appoints Patrick S. Jones as Independent Director Earlier, he held commercial leadership r[+284 characters]
View source ↗ - Newszacks.com·53d ago·Neutral
What's Backing Abbott's Established Pharmaceuticals Division Growth ABT's EPD growth is fueled by emerging-market strength, broad branded generics and healthcare demand, with biosimilars adding opportunities.
View source ↗ - News (RSS)investing·54d ago·Neutral
Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks
View source ↗ - 4chan /biz/biz·54d ago·Positive
Do you know about the HALO trade? Heavy Assets Low Obsolescence HALO It's become basically the counter AI trade. HALO companies are companies with high capital costs, and heavy assets. And big moats. Like a manufacturing company, like Ford or some s***, or Walmart. It's had a low correlation with the AI trade. There's some new HALO etfs, but they have like 70 bps fees or some s***. I'll show you a HALO ETF with dirt cheap fees. SCHD. It's not a perfect HALO tracker but it's like 90% there. A
View source ↗ - Newsprnewswire.com·55d ago·Negative
Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis "We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national blood crisis after donations dropped to a four-year summer low, threatening the availability of lifesaving blood for patients across the country Abbott and the Big Ten
View source ↗ - News (Marketaux)seekingalpha.com·55d ago·Positive
Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript She has held senior commercial leadershi[+334 characters]
View source ↗ - News (RSS)investing.com·55d ago·Neutral
Why is Abbott Laboratories stock gaining today?
View source ↗ - Newsprnewswire.com·56d ago·Negative
Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future Lingo product features Lingo, Abbott's over-the-counter
View source ↗ - News (RSS)yahoo·56d ago·Neutral
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
View source ↗ - Newszacks.com·56d ago·Neutral
Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom? Abbott's Medical Devices growth, EPD momentum and improving Nutrition support its outlook, but China risks, costs and valuation warrant caution.
View source ↗
Earnings
Wed, Oct 21(in 2 weeks)
Consensus estimate $1.42 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 16$1.31 vs $1.28beat
- Thu, Apr 16$1.15 vs $1.14beat
- Thu, Jan 22$1.50 vs $1.50beat
- Wed, Oct 15$1.30 vs $1.30beat
- Thu, Jul 17$1.26 vs $1.26beat
- Wed, Apr 16$1.09 vs $1.07beat
Estimates and results for ABT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ABT officers and directors.
- Bought
- $4.4m
- Sold
- $47.3m
6 trades
10 trades
- Mccoy John A. Jr.sold
- Ford Robert Bsold
- Ford Robert Bsold
- Morrone Louis H.sold
- Stratton John Gbought
- Starks Daniel Jbought
- Boudreau Philip Pbought
- Shroff Ericsold
84 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Rick W. Allenhouse · GA12 · disclosed Aug 19, 2026 (36d later)Sell$15,001 - $50,000
- Rich McCormickhouse · GA06 · disclosed Aug 17, 2026 (18d later)Sell$1,001 - $15,000
- Mike Kellyhouse · PA16 · disclosed Aug 12, 2026 (26d later)Sell$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Sell$15,001 - $50,000
- Richard Ray Larsenhouse · WA02 · disclosed Jul 13, 2026 (5d later)Sell$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Jul 10, 2026 (28d later)Buy$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Jul 10, 2026 (28d later)Buy$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Jul 10, 2026 (28d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2026 (36d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Jul 3, 2026 (17d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Jun 15, 2026 (34d later)Sell$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Jun 9, 2026 (25d later)Sell$1,001 - $15,000
- Rick W. Allenhouse · GA12 · disclosed Jun 8, 2026 (53d later)Sell$15,001 - $50,000
- Josh S. Gottheimerhouse · NJ05 · disclosed Jun 4, 2026 (8d later)Sell$1,001 - $15,000
- Laura Friedmanhouse · disclosed Apr 20, 2026 (27d later)Sell$1,001 - $15,000
- Michael T. McCaulhouse · TX10 · disclosed Apr 10, 2026 (37d later)Sell$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Apr 7, 2026 (19d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Mar 10, 2026 (28d later)Sell$1,001 - $15,000
- Thomas Keanhouse · NJ07 · disclosed Feb 20, 2026 (22d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$15,001 - $50,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
